Oncology & Cancer

New drug combination destroys chemo-resistant blood cancer

Researchers from The Ottawa Hospital and the University of Ottawa have developed a promising targeted strategy to treat chemotherapy-resistant acute myeloid leukemia (AML) and a diagnostic test to determine which AML patients ...

Cardiology

Identifying risk factors following ICH strokes

A new study led by University of Cincinnati researchers provides new insights on how different risk factors following one of the most severe types of stroke can affect patient outcomes.

Cardiology

Adding transition services does not aid heart failure outcomes

(HealthDay)—Additional transitional care services do not improve outcomes for heart failure patients discharged from the hospital, according to a study recently published in the Journal of the American Medical Association.

Medications

Think you're allergic to penicillin? You are probably wrong

More than 30 million people in the United States wrongly believe they are allergic to penicillin—resulting in millions of dollars in added health care costs, adverse side effects from the use of more powerful antibiotics ...

page 36 from 40